<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR53">
 <label>53.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Karpenko</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Deev</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Kiselev</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Charushin</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Rusinov</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Ulomsky</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Deeva</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Yanvarev</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Ivanov</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Smirnova</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Kochetkov</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Chupakhin</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Kukhanova</surname>
    <given-names>M</given-names>
   </name>
  </person-group>
  <article-title>Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza a and B virus replication</article-title>
  <source>Antimicrob Agents Chemother</source>
  <year>2010</year>
  <volume>54</volume>
  <issue>5</issue>
  <fpage>2017</fpage>
  <lpage>2022</lpage>
  <pub-id pub-id-type="pmid">20194696</pub-id>
 </element-citation>
</ref>
